Previous 10 | Next 10 |
2023-07-07 08:16:18 ET What a difference a week can make to a volatile stock. Following a significant swoon late last week, BioXcel Therapeutics (NASDAQ: BTAI) sharply reversed course in the subsequent frame. As of early Friday morning, according to data compiled by S&P Global...
2023-07-06 08:18:59 ET Mullen Automotive ( MULN ) +47% . BioXcel Therapeutics ( BTAI ) +21% . Kazia Therapeutics ( KZIA ) +19% jumps as FDA awards Fast Track tag for lead program. Genius Sports ( GENI ) +12% Genius Sports, Perion N...
NEW YORK, NY / ACCESSWIRE / July 5, 2023 / Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein") announces that it is investigating claims on behalf of investors of BioXcel Therapeutics Inc. (NASDAQ:BTAI) ("BioXcel" or the "Company") for violations of the securities laws. ...
2023-07-05 13:00:26 ET Gainers: Mullen Automotive ( MULN ) +47% . iMedia Brands ( IMBI ) +45% . LightPath Technologies ( LPTH ) +32% . Cibus ( CBUS ) +34% . Impel Pharmaceuticals ( IMPL ) +29% . BioXcel Therapeutics ( BTAI ...
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) is one of today's top gainers. The company's shares are currently up 23.22% on the day to $9.71. BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, utilizing artificial intelligence approaches to develop transformative medicines in...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In BioXcel To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - July 2, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is inve...
2023-06-30 18:27:12 ET Summary BioXcel Therapeutics faces regulatory challenges after the FDA found inconsistencies in one of its clinical trial sites, jeopardizing the supplementary approval of its drug, IGALMI. BioXcel's initiated an internal investigation and independent audit ...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In BioXcel To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - June 30, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is inv...
2023-06-30 08:40:05 ET Renalytix ( RNLX ) +38% jumps 38% after FDA nod for lead product. TOP Financial Group ( TOP ) +25% . Bright Health Group ( BHG ) +19% enters into definitive agreement with Molina Healthcare to sell its California Medicare Adva...
2023-06-30 06:07:11 ET Stock index futures rose early Friday following strong U.S. economic data , which grew much more than initially thought in the first quarter. The focus is now on the U.S. personal consumption expenditures price index, or the Fed's favorite inflation ...
News, Short Squeeze, Breakout and More Instantly...
BioXcel Therapeutics Inc. Company Name:
BTAI Stock Symbol:
NASDAQ Market:
BioXcel Therapeutics Inc. Website:
Focused market-access strategy generates estimated net revenue of approximately $1.1 million, highest quarterly net revenue since commercial launch Represents 90% increase from the prior quarter and 141% increase from the second quarter of 2023 NEW HAVEN, Conn., July 16, 2024 (GLO...
Study achieved its objective and demonstrated no evidence of tachyphylaxis, tolerance, or withdrawal with 180 mcg dose (highest approved dose) For each episode occurring over seven days, a reduction in agitation was observed and no serious adverse events were reported following treatmen...
NEW HAVEN, Conn., May 28, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that CEO Vimal Mehta, Ph.D., will present at the Jef...